Recombinant interferon alpha (rIFN alpha-2b) may retard progression of early primary myelofibrosis

Leukemia. 2009 Jul;23(7):1366-9. doi: 10.1038/leu.2009.90. Epub 2009 May 14.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Disease Progression
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Primary Myelofibrosis / drug therapy*
  • Primary Myelofibrosis / pathology
  • Recombinant Proteins

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins